Tag: Abre venous stent

Abre venous stent “remains safe and effective” out to 24 months,...

The Abre venous stent (Medtronic) remains safe and effective for the treatment of iliofemoral venous obstructive disease out to 24 months. This is according...

ABRE study meets primary safety and effectiveness endpoints

Medtronic has announced the first-ever results from the ABRE clinical study assessing the safety and effectiveness of the investigational Abre venous self-expanding stent system...

VEITH 2019: Abre venous stent study baseline demographic data presented

This video is only available in selected geographies Stephen Black (London, UK) talks to VEITHtv about how the dedicated venous open-cell nitinol Abre stent (Medtronic)...
Abre

IDE study to evaluate Abre Venous Self-Expanding Stent in patients with...

Medtronic has announced the initiation of its investigational device exemption (IDE) study for the Abre venous self-expanding stent system. The ABRE IDE Study will...